Total Pageviews

Fed to Crack Down on Risk-Shifting Deals

A major banking regulator moved on Friday to curb a type of financial maneuver that banks can exploit to make themselves look stronger than they actually are.

The Federal Reserve notified large banks that it was taking aim at so-called risk transfer transactions. Supporters of these complex deals say that they allow banks to protect themselves from future losses on loans or other assets. But regulators are concerned that banks may at times use them to evade the stiffer regulations that have been introduced since the 2008 financial crisis.

In its guidance, the Fed said it would “strongly scrutinize” risk-transfer deals that have a substantial impact on a bank’s balance sheet. Banks that have recently used such transactions include Citigroup, Credit Suisse and UBS. Pension funds, hedge funds and private equity firms may often be on the other side of risk transfer trades.

While risk-transfer deals have been around for years, the temptation to use them has risen as regulators have required banks to increase their capital. To get capital levels up, banks have cut their borrowing and now fund more of their operations with equity they have raised from selling shares. Such changes have made banks more stable. But some bankers claim the changes have made it harder for banks to achieve certain measures of profitability. Risk-transfer deals may offer a way for banks to bolster profits while avoiding the changes intended to make them safer.

A bank, for instance, may have entered a risk-transfer deal with a financial entity with which it is affiliated. There is a big danger with such an arrangement. If the affiliated entity cannot ultimately bear the losses that the bank has transferred in the risk-transfer deal, it may end up failing. And the bank may then have to bail out the entity because of its connection with it. In its guidance, the Fed noted that the bank would still have an “implicit obligation” to the transferred risks.

“Firms are discouraged from entering into such transactions,” the Fed wrote.

Its hard line on these types of arrangements may have been motivated by events during the financial crisis. Banks suffered big losses after they made good on obligations that arose from shadowy deals with affiliates.

The Fed, however, said it would be more tolerant of risk-transfer deals if they were struck with entities that were truly separate.

But it will still scrutinize these to make sure they do not lead to banks’ skimping on capital.

A bank may have $100 of loans, against which it has to hold $8 of capital. To free up all that capital, and get its capital requirement down to zero, the bank may do a deal that transfers the risks of all the loans to an unaffiliated entity. If that entity holds $8 of capital against the loans, regulators most likely will not object, since the entity in theory has the strength to absorb potential losses on the loans.

But if the entity that takes the risk of the loans only has $3 of capital held them, regulators will not be satisfied. They could make the bank hold $5 of capital against the loans to reflect the fact that entity does not hold the full $8 of capital against them.

The Fed said that it would scrutinize risk-transfer deals in the stress tests that it conducted on banks each year.



Ally in $98 Million Settlement on Bias in Auto Loans

Ally Financial agreed on Friday to pay $98 million to settle accusations that it discriminated against minority borrowers who were charged more than white customers for auto loans by car dealers.

Under the settlement, which was announced on Friday by the Justice Department and the Consumer Financial Protection Bureau, Ally will pay $80 million to compensate victims and $18 million to the C.F.P.B.’s civil penalty fund.

The C.F.P.B. found that Ally “had not made sufficient efforts to ensure that it was complying with fair lending laws in its pricing of indirect auto loans,” Richard Cordray, the director of the C.F.P.B., said in a statement announcing the administrative action. Working with the Justice Department, the C.F.P.B. found that 235,000 minority borrowers were paying up to $300 on average more in interest than white borrowers with similar credit profiles.

Those payments came in the form of “dealer markups,” or the percent that car dealerships can charge to arrange loans through banks like Ally. Dealerships can typically charge up to 2.5 percent in fees that they are not required to disclose. The consumer bureau has contended that such discretionary pricing policies have led dealerships to charge nonwhite borrowers more, a violation of the Equal Credit Opportunities Act.

Ally, one of the nation’s largest auto lenders, had previously disclosed that it was facing scrutiny from the consumer protection bureau on concerns that the bank had not done enough to protect borrowers, even indirectly. While the bank agreed to the settlement, it did not agree with the findings.

“Ally does not engage in or condone violations of law or discriminatory practices, and based on the company’s analysis of its business, it does not believe that there is measurable discrimination by auto dealers,” the bank said in a statement. “Regardless, Ally takes the assertions by the C.F.P.B. and D.O.J. very seriously and has agreed to the terms in the orders.” Those terms also include establishing a compliance committee to prevent future discrimination.

Regulators have increased their scrutiny of auto lending as the industry has surged to $97.4 billion, the highest level since the third quarter of 2007, according to a report from the Federal Reserve Bank of New York. At the same time, consumer advocates worry about borrowers who may not know they have been victims of discrimination.

Ally caps the amount of dealer markup at 2 percent to 2.5 percent, depending on the loan’s terms. Still, some advocates say the cap doesn’t go far enough.

“We think that this settlement shows that dealer markup, compared with other compensation systems, is just one that is so fraught with fair lending risk that regulators, and frankly the industry, need to abandon it for something else,” said Chris Kukla, senior vice president at the Center for Responsible Lending, a consumer advocacy group.

The majority of people in the United States need a loan to buy a car, and about 80 percent of them use financing arranged by the dealership. Those dealers, in turn, work with partner banks like Ally. People in the auto industry argue that dealers deserve to be compensated for this one-stop-shop service. Regulators and consumer groups have proposed alternate compensation models, including a flat-fee system, which the auto industry argues would cost consumers money in the long run by eliminating competitive pricing among dealerships.

As part of the settlement, Ally will have to appoint a third-party administrator to identify victims of discriminatory lending practices. Although the average victim paid a few hundred dollars too much, it is unclear whether the C.F.P.B. expects the settlement money to pay individuals a comparable sum. The C.F.P.B. began its examination of Ally’s indirect lending portfolio in September of last year and looked at data from April 2011 to March 2012.

Identifying victims has also been a challenge for regulators and consumer advocates. Loan data, including markups and interest rates offered by banks, is not publicly available. Instead, advocacy groups have had to rely on small bits of information - like part of a borrower’s name - to paint a larger picture of the broader lending landscape.

That lack of specificity has drawn criticism from the auto industry and some lawmakers, who say that hard data is necessary to prove wrongdoing.

The National Automobile Dealers Association released a statement on Friday calling for the consumer bureau to make its findings more transparent.

“N.A.D.A. fully supports our nation’s fair-lending laws and the commitment of federal agencies to eliminate discrimination in the marketplace,” the association said in the statement. “We are encouraged that today’s announcement does not mandate any form of a dealer flat-fee compensation system.”



Weekend Reading: Skipping the Wall St. ‘Wolf’

Martin Scorsese’s film about Jordan Belfort is set join a long list of Wall Street movies that are focused more on frat-boy antics than financial wizardry.

The caricatures personified by Mr. Belfort, Gordon Gekko and the brokers in “Boiler Room” are well-known. “Boiler Room” even includes a long scene with the characters quoting from “Wall Street.”

Here are options for 10 very good (and some so bad they’re great) movies on finance that we’d rather see instead of spending time with our family this holiday.

  1. “Trading Places” Money quote: “The people who own the pork belly contracts are saying, ‘Hey, we’re losing all our damn money, and Christmas is around the corner, and I ain’t gonna have no money to buy my son the G.I. Joe with the kung-fu grip!’”
  2. “Floored” Money quote: Almost every quote in this documentary on the Chicago Mercantile Exchange is unprintable.
  3. “Barbarians at the Gate” Money quote: “Kravis will eat you alive if you let him in.”
  4. “The Secret of My Success” Money quote: “That was the best damn memo I ever read.”
  5. “Other People’s Money” Money quote: “I’ll bet the last company around was the one that made the best goddamn buggy whip you ever saw. Now how would you have liked to have been a stockholder in that company?”
  6. “Working Girl” Money quote: “I have a head for business and a bod for sin. Is there anything wrong with that?”
  7. “Rogue Trader” Money quote: “One of our traders in Singapore got drunk the other night and pulled a moon.”
  8. “American Psycho” Money quote: “I can’t believe that Bryce prefers Van Patton’s card to mine.”
  9. “Too Big to Fail” Money quote: “We don’t do this now, we won’t have an economy on Monday.”
  10. “It’s a Wonderful Life.” Money quote: “Look, we’re still in business, we’ve got two bucks left!” This 1946 film may be the last time a banker was portrayed on film as a decent person.

A look back on our reporting of the past week’s highs and lows in finance.

FRIDAY, DEC. 20

Deutsche Bank to Pay $1.9 Billion Over Troubled Mortgage Securities | The German bank is the sixth entity to reach a settlement with the Federal Housing Finance Agency, which has sued 17 banks and financial institutions. DealBook »

THURSDAY, DEC. 19

S.E.C. Tension as It Weighed Mortgage Cases | The reasoning behind the decisions and the contentious way they divided camps within the agency illuminates how difficult choices are made inside the regulator. DealBook »

Investors’ Story Left Out of Wall St. ‘Wolf’ Movie | Left untold in a film about the penny-stock swindler Jordan Belfort and his firm, Stratton Oakmont, are the stories of the investors. DealBook »

Jury-Room Demonstration Persuaded Holdouts in Ex-Trader’s Trial | The jury reached its verdict of guilty in Michael S. Steinberg’s insider trading case soon after one juror convinced a holdout by having her walk through a doorway. DealBook »

Big Subprime Mortgage Loan Servicer Agrees to $2.2 Billion Settlement | Ocwen Financial said on Thursday that it had agreed to pay $2.1 billion to settle accusations that it improperly handled the loans of homeowners. DealBook »

Seafood Chain to Be Split From Darden’s Empire | Darden Restaurants announced that it would jettison its Red Lobster chain, one of several steps it said it would take to bolster its stock value. DealBook »

Facebook to Offer More Shares to the Public | When the markets open on Monday, Facebook will be a member of the Standard & Poor’s 500-stock index. DealBook »

Perelman Gives $50 Million to Hospital | The 10-year gift will go for the construction of an expanded NYU Langone emergency department that will triple the size of old unit. DealBook »

WEDNESDAY, DEC. 18

Ex-Trader at SAC Is Found Guilty | Michael S. Steinberg is the highest-ranking employee at SAC Capital Advisors to become ensnared in a sweeping insider trading investigation. DealBook »

More SAC Employees Depart as Firm Shifts Focus | Some expect departures from SAC Capital, which has pleaded guilty to federal charges, to quicken after the firm fully pays out year-end bonuses. DealBook »

Bitcoin, Nationless Currency, Still Feels Governments’ Pinch | A recent succession of moves by governments around the world has cast doubts on the legitimacy of the virtual currency. DealBook »

Wall Street Sees Hollywood as a Gateway to Sports and Entertainment | While previous generations of financiers have viewed the talent business as a vanity project, newer deals show that investors are set on remaking the industry. DealBook »

TUESDAY, DEC. 17

Brash Agent Extends Reach in a Big Merger | Ari Emanuel’s company, working with its private equity partner, Silver Lake Partners, won a bidding war with an offer of about $2.3 billion. DealBook »

Deal Professor: Despite Deal Activity Doldrums, a Few Highlights This Year | The number of takeovers is down so far this year, but there were a few interesting ones. The Deal Professor grades the best and worst of them. DealBook »

MONDAY, DEC. 16

S.E.C. Seeks Stiff Fines for Tourre | Four months after being found liable for defrauding investors in a soured mortgage deal, the former Goldman Sachs trader faces $910,000 in fines. DealBook »

DealBook Column: Big Bonuses, But a Shift in Who Gets the Biggest | In a shift of rainmakers on Wall Street, asset and hedge fund managers are edging out bankers when it comes to the size of year-end bonuses, writes Andrew Ross Sorkin. DealBook »

Insider Trading Trial of Former SAC Manager Goes to the Jury | The fate of a former top trader for the hedge fund SAC Capital Advisors hinged on whether or not jurors believed the government’s star witness. DealBook »

Volcker Rule Quickly Hits Utah Bank | Zions Bancorporation says it is taking a charge of $387 million to rid itself of a sizable portfolio of trust-preferred collateralized debt obligations and other C.D.O.’s. DealBook »

SUNDAY, DEC. 15

$5 Billion Deal Is Expected For A.I.G.’s Jet Leasing Arm | The big aircraft leasing unit, regarded as one of the crown jewels in A.I.G.’s empire, was sold a competing business, AerCap Holdings of the Netherlands. DealBook »

WEEK IN VERSE

‘Charlie Brown Christmas Dance’ | If your office party includes dancing, just steal the little red-haired girl’s moves. YouTube »



Jazz Deal for Gentium Shows Benefits of Inversions

In 2011, Jazz Pharmaceuticals, a California-based drug maker, acquired Azur Pharma, a small rival based in Ireland.

Because the stock deal transferred more than 20 percent ownership of the combined company to foreign holders, Jazz was able to enact an “inversion” â€" relocating its corporate headquarters to Ireland and escaping the U.S. tax regime.

Jazz’s deal for Azur was part of a new wave of inversions that is occurring as U.S. companies look for tax relief wherever they can find it. And Ireland has proven a popular destination for inverted companies, thanks to its relatively low tax rate. Just this year, Michigan-based Perrigo, another drug company, inverted when it bought Elan, an Irish drug maker for $6.7 billion; Actavis, another U.S. pharmaceutical company, inverted when it bought Dublin-based Warner Chilcott; and Endo Health Solutions, based in Pennsylvania, bought a small Canadian rival, but said it would move its headquarters to Ireland.

In addition to the basic savings companies achieve by not paying taxes on their international profits, a big reason companies invert is so they can acquire companies on a tax-efficient basis. And on Friday, Jazz took full advantage of that benefit, agreeing to to buy Gentium, a U.S. drug maker, for about $1 billion.

Had Jazz still been a U.S.-domiciled corporation, it would have had to pay higher taxes on the deal, and earnings from Gentium’s products would have been taxed at the higher rate. But because Jazz is now based in Ireland, it will be able to save taxes on the deal, and significantly reduce its tax bill on future profits from business lines it is acquiring from Gentium.

On a conference call with analysts after the deal was announced, Jazz executives nodded to the advantages of their inversion, without ever mentioning the maneuver by name.

“We have a tax structure that we believe is good for our current business but also allows us to competitively acquire additional assets into our business,” said Bruce C. Cozadd, Jazz’s chief executive.

For example, one way Jazz might take advantage is by locating any debt it needs for the deal in its U.S. subsidiary, thereby offsetting any taxes it might have to pay on U.S. profits.

Explaining the expected synergies, the tax savings were top of mind. “We think it slots very well into our international the tax structure,” said Jazz’s chief financial officer, Kathryn E. Falberg. “So we certainly think that this does leverage the fact that we do have an efficient corporate structure.”

As more companies have inverted in recent years, Washington has once again turned its attention to the thorny issue of how to protect the government’s tax base. Senator Max Baucus recently proposed an overhaul of the corporate tax code that would curtail inversions, but also exempt overseas earnings from U.S. taxes.

But with Mr. Baucus now set to become President Obama’s next ambassador to China, it seems unlikely that any changes to inversion rules are imminent. That means companies like Jazz are likely to be able to continue to take advantage of inversions and all they have to offer for a long time to come.

“Could there be changes in tax laws in the future?” Mr. Cozadd said on Friday. “Absolutely, there could be. I think some of those could actually be beneficial, particularly to the extent the U.S. decides at some point that one of the reasons companies pursue some of these transactions is because on a relative basis, the U.S. tax rate of course, is very, very high.”

Jazz did not respond to requests for comment.



Wells Fargo Poised for Wall Street Run

Wells Fargo will start knocking more loudly on the bulge bracket’s door. The California lender is already one of the top 10 global investment banks by fees, according to data from Thomson Reuters. Much of that comes courtesy of middle-market clients. But if the bank run by John Stumpf starts going after bigger fish, it could put Wall Street’s bigwigs on the defensive.

Mr. Stumpf has been expanding Wells’ investment banking business ever since picking up Wachovia, which had been making a move on Wall Street, in 2008. The bank is not much of a trading house. What little information it provides shows that a day where it makes more than $15 million in revenue is a big one, compared with the $100 million marker the likes of Goldman Sachs lay down. At $2 billion, though, the underwriting and advisory fees earned in the first 11 months of 2013 are already double the bank’s take for the whole of the first year after Wells purchased Wachovia.

America’s fourth-largest bank by assets still has room to grow. Its equity capital markets division had just a 5 percent share of the U.S. market in the year to November. While that’s an impressive jump from its 1.7 percent showing in 2009, it’s less than half of what the top four players each command. The gap is even starker in advising on mergers. Wells’ 2.5 percent share is five times its 2009 number. But it advised on only $53 billion worth of deals - a tenth of market leaders Goldman Sachs and JPMorgan.

Yet Mr. Stumpf’s firm has the balance sheet, and lending relationships, to do better. Its loan-to-deposit ratio is just 79 percent, meaning Wells has $200 billion of lending firepower, should it choose to deploy it more aggressively. While explicitly tying loans to other business is verboten, it does provide a handy calling card - as JPMorgan and other megabanks have shown in the past.

Taking on Wall Street’s old guard won’t be easy. Corporate executives and their boards don’t like trying out newcomers for selling stock or inking transformational deals. That’s why Wells’ run in the debt business is more noticeable - it underwrote more high-yield bond deals this year than Morgan Stanley, for example. Advising on takeovers is a harder nut to crack and faces extra competition from boutiques. But the returns are hefty enough that Wells may find the lure of a more enduring Wall Street presence irresistible.

Antony Currie is an associate editor at Reuters Breakingviews. For more independent commentary and analysis, visit breakingviews.com.



For a Hedge Fund Pioneer, a Tiger Fund Burning Bright

Julian Robertson, the billionaire investor and an early pioneer of the hedge fund industry, is  again proving to be a top picker of new talent.

His $450 million Tiger Accelerator Fund, which invests in six hedge funds that Mr. Robertson personally has invested in, is up 22.6 percent net of fees as of Dec. 15, according to a person briefed on the matter. By comparison, the broadest hedge fund industry index is up just about 9 percent for the year.

Mr. Robertson began the Tiger Accelerator Fund in 2011, marking a return to the hedge fund industry after shuttering his Tiger Management fund in 2000. Tiger Management, with $22 billion at its peak, once was one of the industry’s largest funds and delivered annual returns of nearly 30 percent before slumping in 1999 and 2000.

Mr. Robertson helped start the careers of a number of notable hedge fund managers including Chase Coleman of Tiger Global, Lee Ainslie of Maverick Capital and Andreas Halvorsen of Viking Global Investors.

Overall, Mr. Roberston has provided seed capital or early investment money to about 40 hedge funds. In the hedge fund world, funds that either have received investment money from Mr. Robertson or were founded by traders who once worked for him are sometimes referred to as Tiger cubs.

The six hedge funds that the Tiger Accelerator Fund’s performance tracks are Tiger Veda, Cascabel, Long Oar Global, Tiger Eye, Tiger Ratan and Tiger Veda Global. The Accelerator fund’s $450 million investment is on top of the roughly $230 million Mr. Robertson committed of his own money to those funds.

Unlike other seeder funds that tend to commit money to new funds with a relatively short track record, the Accelerator fund selected six funds that had several years of operation behind them. Mr. Robertson tapped the services of Morgan Stanley to market his seeder fund to investors, which raised most of its money during the first-half of 2011.



Beating Back Pain

Two months ago, I stepped into a shower in a hotel room in Baton Rouge, La., and felt a slight twinge in my back. I didn’t pay it much mind. I’ve experienced twinges from time to time, but for more than 25 years, I have been essentially free of back pain.

As you’ve probably guessed, that twinge didn’t go away. Instead, it got worse. It lodged in my lower back, and I could feel the sciatica all the way down to my knee. Within a week, I couldn’t walk more than 100 yards without severe pain.

Among other things, I was embarrassed. In 1987, I wrote an article in New York magazine called “Ah, My Non-Aching Back,” about how I’d found relief through a doctor named John E. Sarno.

By the time I saw Dr. Sarno, I had spent a year in relentless pain, visiting orthopedists and chiropractors, osteopaths and acupuncturists, trying yoga, physical therapy and bed rest, all to no avail.

Dr. Sarno’s treatment was essentially a talking cure. His theory, stated simply, is that back pain develops as a way of unconsciously shifting attention away from uncomfortable feelings such as anger and anxiety. With rare exceptions, Dr. Sarno believes, back pain has no structural basis. Rather, it is almost always a consequence of muscle spasm that prompts pain, which leads to fear, and then more spasm, and eventually creates a vicious cycle of pain. He named the condition tension myositis syndrome.

My prescription was to attend two lectures that Dr. Sarno gave describing the syndrome and the pain cycle, and why there was nothing to worry about except the fear itself.

I attended the talks with several dozen other patients. By the day after the first lecture, my pain was receding. In a couple of weeks, I was out of pain. For all practical purposes, it never returned - until this fall. (If you want a fuller description of T.M.S., you can read my article or one of Dr. Sarno’s books, including “Healing Back Pain” and “Mind Over Back Pain.”

Over the years, I’ve sent dozens of people to Dr. Sarno, including ones who had suffered from back pain for years, had visible herniated discs on their MRI scans, and in some cases, had gone through multiple surgeries. Nearly all of them had the same experience I did: complete relief.

When my pain resurfaced this fall, I naturally assumed it was T.M.S. again. I wondered what anxiety in my life I might be trying to avoid, and came up with a plausible theory that I won’t burden you by sharing. The problem was, I didn’t get better.

I tried to remind myself that my pain was essentially harmless - much the way any muscle spasm is â€" but it felt like a distinction without a difference. As the days passed, I could feel my fear intensifying. I became preoccupied with my pain, monitoring its every fluctuation. I began restricting my movements in an effort to keep the pain at bay. I was seriously doubting the experience and wisdom that had served me so well for so long.

After about 10 days, I told myself that I simply needed to be reassured that there was nothing wrong with me. Dr. Sarno has retired, so I went to see his successor, Ira G. Rashbaum, at NYU Langone Medical Center. In minutes, he concluded that it was, indeed, T.M.S. “You’re going to be fine,” he reassured me.

The next morning, my pain was just as severe as it had been the previous day. It was time, I decided, to address the fear more directly. By this point, I’d given up my daily 30-minute run on a treadmill. I decided to try to resume walking for three minutes at a time, even if it hurt a lot. Sure enough, the first day was excruciating, and I fought with myself not to quit. I managed to do four three-minute walks, sitting down to rest between each one.

The second day, the pain was still significant, but I felt more confident that I could bear it, and this time I was able to walk 15 minutes altogether. The following day, I got to 20. On the fourth day, I was able to walk the 30 minutes without stopping, and on the fifth, I began to mix walking with light jogging.

Even then, it was excruciating at first. But the longer I ran, the more the pain receded, only to reappear when I tried to walk during the day. The difference now was that the pain no longer prompted much fear. If it disappeared when I ran, there was plainly nothing structurally wrong with me. The spasm, I decided, was just taking its time to subside.

I spend a good percentage of my life giving talks. As luck would have it, there were no talks on my schedule during the three weeks I had been suffering, but several days after resuming my runs, I had one to give.

I felt apprehensive about having to stand up for 90 minutes, and I arranged to have a stool on the stage, just in case. I dreaded having to use it. It’s not exactly inspiring to speak in front of 200 people while sitting on a stool.

As I began my talk, I was mildly aware of some pain, but then I became absorbed in what I was saying. When I finished, I realized I felt fine. That was nearly five weeks ago. I’ve been pain-free ever since.

I’ve told you this story for two reasons.

First, research suggests that one-third to one-half of us suffer from back pain, and I know all too well how preoccupying, depressing and disabling it can be. I’m also convinced we are squandering hundreds of millions of dollars and countless hours seeking well-meaning practitioners who fail to understand the real cause of back pain.

The second reason I’ve shared my story is to point out how much the power of fear - which we generate ourselves â€" can take control of our lives. Had I not taken on my fear and deliberately confronted my pain, I have no doubt I would be even more disabled today than I was at my worst two months ago. Instead, I’m heading into the holidays pain-free and emboldened to take on my fear in whatever guise it next arises.

About the Author

Tony Schwartz is the chief executive of the Energy Project and the author, most recently, of “Be Excellent at Anything: The Four Keys to Transforming the Way We Work and Live.” Twitter: @tonyschwartz



Deutsche Bank to Pay $1.9 Billion Over Troubled Mortgage Securities

Deutsche Bank agreed on Friday to pay about $1.9 billion to settle claims that it misled Fannie Mae and Freddie Mac over the quality of home loans bundled into mortgage-backed securities, becoming the latest big bank to reach a settlement with federal housing regulators.

The bank, based in Germany, is the sixth entity to reach a settlement with the Federal Housing Finance Agency, which has sued 17 banks and financial institutions in September 2011. The agency says the institutions misled Fannie and Freddie before the financial crisis over the creditworthiness of borrowers and the quality of the loans that were packaged into securities.

Deutsche Bank said in a news release that it had largely set aside money in its legal reserves to pay for the settlement, which it said “resolves its single largest mortgage-related litigation issue.” About $1.6 billion of the settlement will go to Freddie Mac and $300 million will go to Fannie Mae.

The pace of settlements between the Federal Housing Finance Agency and the banks it sued has picked up in the last few months as Wall Street institutions look to put litigation arising from the financial crisis and the collapse of the American housing market behind them.

The dollars collected by the agency, which is the conservator for Fannie and Freddie, are quickly rising. The agency has collecting more than $5 billion from JPMorgan Chase and $885 million from UBS. Several other banks are in negotiations to settle their cases.

In its lawsuits, the regulator said that some of the losses Fannie and Freddie incurred on mortgage-backed securities stemmed from financial institution selling securities that were flawed because many of the home loans in those bonds were riskier than the banks had represented. The agency has sued Deutsche, JPMorgan, Citigroup, Bank of America and other institutions seeking to recoup some of $196 billion that Fannie and Freddie had spent buying up the so-called private-label mortgage-backed securities.

The regulator said in a statement that it was “committed to satisfactory resolution of the remaining actions” it has filed. In addition, to Deutsche Bank, JPMorgan and UBS, the agency has reached settlements with Citigroup and General Electric‘s financing arm.

Of the banks that have yet to settle, Bank of America faces the greatest potential exposure. That bank, along with firms that it acquired like Countrywide Financial, were responsible for selling more faulty mortgage securities to Fannie and Freddie than other institutions, according to the regulator.

A Bank of America spokesman declined to comment on the litigation.



S.E.C. Mired in Tensions Over Mortgage Cases

 |  TENSION AT S.E.C. OVER MORTGAGE CASES After months of investigating the role of Goldman Sachs, Wells Fargo and others in troubled mortgage securities â€" and even warning that enforcement actions were possible â€" the Securities and Exchange Commission shelved those cases and at least two others.

Behind that decision was a a series of arguments about whether Wall Street’s top regulator had evidence strong enough to prevail at trial, DealBook’s Peter Eavis and Ben Protess report. That internal tension raises questions about whether the agency could have done even more after the crisis to hold Wall Street accountable.

Some of those decisions traced to concerns about the evidence, with senior officials questioning whether the investigators’ devotion to the cases had colored their judgments. Other times, the decisions came down to dollars and cents.

INSIDE THE STEINBERG TRIAL JURY ROOM After more than nine hours of deliberations, the 12 jurors couldn’t decide whether Michael S. Steinberg, a former top trader at SAC Capital Advisors, explicitly knew that his subordinate was giving him illegal tips.

But on Wednesday, the group had a breakthrough, and by 2:59 p.m. voted to convict the onetime hedge fund executive of five counts of insider trading, DealBook’s Alexandra Stevenson and Rachel Abrams report.

Interviews with five of the 12 jurors â€" a diverse group that included two accountants and a former postal worker â€" showed that they had grappled with the financial jargon of a complicated Wall Street insider trading case.

Their decision has given federal prosecutors both a victory and more confidence in their broad-ranging campaign against insider trading, White Collar Watch’s Peter J. Henning writes. It was a hard-fought win, especially since Mr. Steinberg was a fourth-level recipient of insider information who never dealt with any of its original sources.

THE INVESTORS’ SIDE OF ‘THE WOLF OF WALL STREET’ The tale of Jordan Belfort is hitting movie theaters on Christmas Day, as Leonardo DiCaprio and Martin Scorsese retell how the broker swindled thousands of investors out of more than $100 million in a boiler room scam.

But left untold in “The Wolf of Wall Street” is the story of his victims, disparaged as “garbage” in the movie, Susan Antilla writes in DealBook. For many, including small-business owners and insurance agents, the film’s publicity has brought back old pain.

That’s not the only element missing from the cinematic romp. Joe Nocera writes in The New York Times that “The Wolf of Wall Street” doesn’t touch on the part of the finance industry that caused the financial crisis.
“Firms like Stratton Oakmont can’t bring the financial system to the precipice,” Mr. Nocera writes, adding that using the brokerage as a proxy for Wall Street “doesn’t begin to get at Wall Street’s sins.”

PERELMAN GIVES $50 MILLION TO HOSPITAL Ronald O. Perelman’s visit to his father-in-law at the hospital last year opened his eyes and inspired his latest bout of philanthropy.

The financier announced on Thursday that he would donate $50 million to finish the construction of an expanded emergency department for the NYU Langone Medical Center in Lower Manhattan, Ms. Abrams reports.

“I just don’t think it’s fair to the people who lived down there to have to go all the way up to New York hospital at 72nd Street to get emergency treatment,” Mr. Perelman said in an interview.

Mergers & Acquisitions »

$2.4 Billion Deal for Hong Kong Wireless Business$2.4 Billion Deal for Hong Kong Wireless Business  |  The billionaire Richard Li is raising his bet on telecommunications, agreeing on Friday to acquire CSL New World Mobility from Australia’s Telstra.
DealBook »

Jazz Pharmaceuticals to Buy Gentium for $1 Billion  |  Jazz Pharmaceuticals has agreed to acquire Gentium, a developer of treatments for rare diseases, in a deal valued at about $1 billion.
DealBook »

Calculating the Benefits of a Charter-Time Warner Cable Deal  |  Executives at Liberty Media, whose chairman, John Malone, owns 27 percent of Charter Communications, believe a Charter tie-up with Time Warner Cable could achieve about $700 million in annual cost savings, Reuters reports.
Reuters

Hershey Goes to China for Its Biggest-Ever DealHershey Goes to China for Its Biggest-Ever Deal  |  Hershey announced on Thursday that it had agreed to buy an 80 percent stake in Shanghai Golden Monkey for about $584 million.
DealBook »

Red Lobster to Be Split From Darden’s EmpireRed Lobster to Be Split From Darden’s Empire  |  Darden Restaurants announced that it would jettison its Red Lobster chain, one of several steps it said it would take to bolster its stock value.
DealBook »

E.ON Considering Sale of Spanish Businesses  |  The German utility E.ON considers selling its Spanish businesses, Reuters reports.
Reuters

Trouble Assessing JPMorgan’s Commodities Unit  |  Potential bidders for a commodities trading business owned by JPMorgan Chase, which include some of its closest rivals, say the bank is declining to release information about the unit, making it difficult to value the operation, The Financial Times writes.
Financial Times

Evonik Invited to Make New Bid For LTS Lohmann  |  Reuters writes: “The owners of German medical skin patch maker LTS Lohmann have invited Evonik to make a new bid for the company after finding final offers from other bidders unsatisfactory.”
Reuters

Italian Post Office to Invest 75 Million Euros in Alitalia  |  Poste Italiane, the state-owned company that runs the Italian postal system, will pay 75 million euros, or about $103 million, to take a stake in the airline Alitalia, The Wall Street Journal reports.
Wall Street Journal

Deal to Give Daimler Stake in Aston Martin  |  Daimler will get as much as a 5 percent stake in Aston Martin as part of a deal to supply the British sports carmaker with engines and other components, Reuters writes.
Reuters

Panasonic to Form Joint Venture With Israeli Firm  |  The Panasonic Corporation and the Israeli chipmaker TowerJazz are forming a joint venture to manufacture computer chips for automobiles and products, Reuters reports.
Reuters

Real Estate Trusts in $4.34 Billion Merger  |  Essex Property Trust, a residential real estate investment trust with a strong California presence, has agreed to acquire BRE Properties.
DealBook »

INVESTMENT BANKING »

Not So Fast on Volcker Rule, Regulators Tell Smaller BanksNot So Fast on Volcker Rule, Regulators Tell Smaller Banks  |  Just three days after Zions Bancorporation took a $387 million charge to rid itself of trust-preferred C.D.O.’s, regulators said other banks need not necessarily do the same.
DealBook »

Loophole Slowly Tightens on a Bank  |  It wasn’t bad loans that created big losses for Zions Bankcorporation, it was ill-fated and ill-timed financial innovation, Floyd Norris of The New York Times writes.
New York Times

Fed to Remain Large Player in Mortgage Security Market  |  The Federal Reserve will continue to play a large role in the mortgage security market despite efforts to shrink its buying of bonds, The Wall Street Journal reports.
Wall Street Journal

Deal on Banking Union Will Test Goal of United Europe  |  The effort to create a banking union has highlighted how difficult it is to act ambitiously for a bloc that has grown from six to 28 member states, The International New York Times writes.
International New York Times

Lloyds and R.B.S. Seek to Regain Independence  |  The Lloyds Banking Group and the Royal Bank of Scotland are on much different paths as they seek to gain independence from the British government five years after their bailouts during the financial crisis, Reuters reports.
Reuters

Credit Suisse Gains a Top Energy Banker  |  Brian McCabe is leaving Morgan Stanley and joining the Swiss investment bank as co-head of its Americas oil and gas group. He will be based in Houston.
DealBook »

Citi to Move Headquarters to Lower Manhattan  |  Citigroup has agreed to move its global headquarters to Greenwich Street in Lower Manhattan in a $1 billion real estate deal, Crain’s New York reports.
Crains New York

PRIVATE EQUITY »

Jones Group to Be Bought Out by SycamoreJones Group to Be Bought Out by Sycamore  |  The Jones Group, which owns brands including Nine West, Anne Klein and Easy Spirit, will be acquired by Sycamore Partners for $2.2 billion, including the assumption of debt.
DealBook »

Carlyle Takes Stake in Indian Health Care Company  |  The private equity firm the Carlyle Group is taking a stake in Global Health, an Indian health care provider, Reuters reports.
Reuters

Investors Cutting Ties With ConvergEx After Plea  |  After paying a $150 million fine and a guilty plea by a subsidiary related to charges of “fleecing” of clients, several large investors have redirected their trading activity from ConvergEx, which is controlled by the private equity firm GTCR and Bank of New York Mellon, The Financial Times reports.
Financial Times

Invesco Manager to Join Britain’s Oakley Capital  |  Neil Woodford, head of British equities at Invesco Perpetual, has agreed to join the British private equity firm Oakley Capital in May in an unspecified role, The Financial Times reports.
Financial Times

HEDGE FUNDS »

Skowron to Repay Morgan Stanley After Guilty Plea  |  A federal judge ordered the former Morgan Stanley fund manager Joseph Skowron to repay $31 million in compensation as part of a clawback lawsuit by the bank after he pleaded guilty to insider trading two years ago, Bloomberg News reports.
Bloomberg

BlackRock Raising $3 Billion For Credit Fund  |  BlackRock is looking to raise as much as $3 billion for a new hedge fund to focus on investing in the credit markets, Bloomberg News reports.
Bloomberg

Tiger Asia Hedge Fund Ordered to Repay $5.8 Million Over Illegal Trading  |  Tiger Asia, a regional arm of the New York-based hedge fund Tiger Management, admitted that it had received advanced notice in late 2008 and early 2009 that two Chinese banks were planning share placements.
DealBook »

Can General Electric Keep Activist Investors at Bay?Can General Electric Keep Activist Investors at Bay?  |  Size offers no immunity, and the conglomerate has been proactively restructuring in ways that could wisely head off investor pressure, writes Rob Cox of Reuters Breakingviews.
DealBook »

BlueCrest Capital Taps Bank Loan to Fund Expansion  |  BlueCrest Capital Management received a $750 million bank loan earlier this year as part of a rapid expansion of the European hedge fund, Bloomberg News reports.

Bloomberg

I.P.O./OFFERINGS »

China Everbright Bank Shares Fall on Trading Debut  |  The trading slump came after the bank raised $3 billion in Hong Kong’s biggest initial public offering of the year, and despite generally strong market receptions for new Chinese share sales in recent weeks.
DealBook »

VENTURE CAPITAL »

Overstock.com to Accept Bitcoin Payments  |  Overstock.com is planning to accept payments from Bitcoin, making it the first large online retailer in the United States to accept the virtual currency, The Financial Times reports.
Financial Times

China’s Central Bank Targeted in Cyber Attack  |  The Times of London writes: “China’s central bank is thought to have been targeted yesterday in a revenge cyber-attack by investors infuriated at government attempts to destroy the local Bitcoin market.”
Times of London

LEGAL/REGULATORY »

Ocwen Financial Agrees to $2.2 Billion SettlementOcwen Financial Agrees to $2.2 Billion Settlement  |  Ocwen Financial said on Thursday that it had agreed to pay the $2.2 billion to settle accusations that it improperly handled the loans of homeowners after the financial crisis.
DealBook »

Deutsche Bank Securities Is Fined $6.5 Million  |  The Financial Industry Regulatory Authority has fined Deutsche Bank Securities $6.5 million over “serious financial and operational deficiencies primarily related to its enhanced lending program.”
DealBook »

Ex-Microsoft Employee Charged With Insider Trading  |  The Seattle Times writes: “A former Microsoft finance manager and his day-trading friend appeared in federal court Thursday on charges they used insider information to raise seed money for their dream of owning a hedge fund.”
Seattle Times

Banks Turning in Competitors in Currency Trading Inquiry  |  Banks are turning in their competitors in hopes of avoiding fines in an European Union investigations into potential manipulation of the currency trading markets, Bloomberg News reports.
Bloomberg

Italy Investigating Reorganization of Telecom Italia’s Holding Company  |  Reuters writes: “Rome prosecutors are investigating the reorganization of the shareholding of Telco, the holding company that controls Telecom Italia, the chief prosecutor said.”
Reuters

Ex-Stock Broker Pleads Guilty to Insider Trading  |  David Weishaus, a former stock broker, pleaded guilty to a conspiracy charge in a scheme to improperly trade ahead of the announcement of a $1.2 billion acquisition by IBM in 2009, Reuters reports.
Reuters

Forbes Family in Tax Dispute Over Former Headquarters  |  The Wall Street Journal writes: “Steve Forbes and members of his family are enmeshed in a tax dispute with the Internal Revenue Service tied to their publishing company’s former New York headquarters, documents filed in U.S. Tax Court reveal.”
Wall Street Journal

S.&P. Pulls AAA Rating From E.U.  |  Standard & Poor’s has downgraded the European Union from triple A to AA-plus, citing continued financial concerns and disagreements about its budget, The Financial Times writes.
Financial Times



Europe to Investigate Telefónica Deal for German Mobile Operator

LONDON - European antitrust regulators said Friday that they had opened an in-depth investigation into the Spanish telecommunications company Telefónica’s agreement to buy Germany’s smallest mobile operator, E-Plus, from its Dutch rival KPN.

The European Commission said it was examining whether the transaction will unfairly reduce competition in the mobile phone and telephone services sector in Germany. Regulators will issued a decision by May 14.

Telefónica, based in Madrid, agreed in July to acquire E-Plus in a cash-and-stock deal with an implied value of 8.1 billion euros, or about $11.1 billion.

“The commission has concerns that the transaction would remove an important competitive force and change the merged entity’s incentive to exert significant competitive pressure on the remaining competitors,” the European Union said in a statement on Friday.

The deal would reduce the number of mobile telephone network operators in Germany to three from four, and would create a rival on par with T-Mobile and Vodafone, which combined account for more than half the mobile telephone market in Germany.

As part of its investigation, the European Commission will examine the combined entity’s incentives to compete after the merger, the likely reaction of competitors and the possible positive effects for consumers related to the rollout of 4G mobile networks.

The investigation comes amid a wave of restructurings in the European telecom industry, with companies looking to consolidate or sell non-core assets.

The largest deal by far this year was Vodafone’s decision in September to sell its 45 percent stake in Verizon Communications’ wireless unit in the United States for $130 billion.

Since then, there have been a flurry of asset sales by telecom firms.

In November, Vivendi announced plans to spin off its mobile and telecom unit SFR after shedding a 53 percent stake in its Moroccan business for €4.2 billion. Last month, PPF Group announced it planned to acquire a controlling stake in Telefonica’s Czech Republic operations for €2.5 billion.

Deutsche Telekom also agreed in November to sell a 70 percent stake in its online classified advertising business for €1.5 billion and the French telecommunications company Orange reached a deal to sell its Dominican Republic operations for $1.4 billion.



Oracle to Buy Responsys for $1.5 Billion

Oracle said on Friday that it had agreed to acquire Responsys, an enterprise software company, for $27 per share in cash, or about $1.5 billion, not including debt.

It is the latest acquisition for Oracle, run by Lawrence J. Ellison, and further extends the company’s reach into the realm of online marketing. Responsys makes software that allows brands to coordinate their email, mobile, display and social advertising across the web.

The price of $27 per share amounts to a 38 percent premium above Responsys’ closing stock price of $19.52 on Thursday.

“Responsys has always been focused on helping marketers realize their largest opportunity â€" coordinating their marketing touch points across channels, across the customer lifecycle, and across industries,” Dan Springer, chief executive of Responsys, said in a statement. “As a part of Oracle, we will only accelerate our efforts.”

The board of Responsys has approved the transaction, but shareholders will have the opportunity to vote on the deal early next year.

“Our strategy of combining the leaders across complementary technologies signifies Oracle’s overwhelming commitment to winning and serving the CMO better than any other software company in the world,” said Oracle’s president, Mark Hurd.

Oracle is one of the most prolific acquirers in Silicon Valley. Including Responsys, it has bought at least seven companies this year. Earlier this year it struck a deal for Acme Packet for $2.1 billion

But Oracle has had a few rough quarters recently, missing analyst expectations twice earlier in the year before posting good quarterly results earlier this week. Those results sent Oracle stock to its highest levels since the dot com bubble burst more than 10 years ago.

In October, Oracle shareholders opposed Mr. Ellison’s compensation package, objecting to his $78.4 million payday for the 2013 fiscal year.

Responsys was part of first wave of technology companies to go public after the financial crisis, debuting on the Nasdaq market in early 2011. After opening near $15, the stock slumped as low as $5.70 about a year ago. But over the last year the business has strengthened and shares have rallied. Thursday’s closing price was near the all time high.

No advisers were listed on the deal.



Jazz Pharmaceuticals to Buy Gentium for $1 Billion

LONDON - The Irish drug maker Jazz Pharmaceuticals agreed to acquire Gentium in a deal valued at about $1 billion, diversifying its portfolio of treatments for rare diseases.

A Jazz subsidiary will make an all-cash tender offer of $57 a share for all of Gentium’s ordinary stock and American depositary shares. Gentium’s shares were down 1.3 percent to $55.65 at the close of trading on Nasdaq on Thursday.

Gentium, an Italian biopharmaceutical company that develops treatments for rare diseases, was granted approval in October by the European Commission to sell its keynote drug Defitelio, a treatment for severe hepatic veno-occlusive disease.

“Incorporating Gentium into Jazz Pharmaceuticals is a strong strategic fit as Defitelio would diversify our development and commercial portfolio and complement our clinical experience in hematology/oncology and our expertise in reaching targeted physicians who treat serious medical conditions,” said Bruce Cozadd, Jazz’s chairman and chief executive.

The transaction has been approved by the boards of both companies and Gentium’s board, management and certain shareholders have agreed to tender their shares, representing about 15 percent of the company’s stock. The deal is conditioned on at least 66.7 percent of the company’s shares being tendered.

The deal is expected to close in the first quarter of 2014.

Through the first nine months of the year, Jazz posted revenue of $636.6 million, a 58 percent increase over the prior-year period.

Jazz is financing the transaction with a combination of cash on hand as well as an incremental term loan and borrowings under its existing senior secured credit facility. Barclays, its financial adviser, also has committed to a $500 million incremental term loan.

Jefferies served as Gentium’s financial adviser. . Gentium’s legal advisers were Skadden Arps Slate Meagher & Flom and Gianni, Origoni, Grippo & Cappelli.

Jazz’s legal counsel were Weil, Gotshal & Manges; Baker & McKenzie; Cooley; Hogan Lovells; and Gattai, Minoli & Partners.



Jazz Pharmaceuticals to Buy Gentium for $1 Billion

LONDON - The Irish drug maker Jazz Pharmaceuticals agreed to acquire Gentium in a deal valued at about $1 billion, diversifying its portfolio of treatments for rare diseases.

A Jazz subsidiary will make an all-cash tender offer of $57 a share for all of Gentium’s ordinary stock and American depositary shares. Gentium’s shares were down 1.3 percent to $55.65 at the close of trading on Nasdaq on Thursday.

Gentium, an Italian biopharmaceutical company that develops treatments for rare diseases, was granted approval in October by the European Commission to sell its keynote drug Defitelio, a treatment for severe hepatic veno-occlusive disease.

“Incorporating Gentium into Jazz Pharmaceuticals is a strong strategic fit as Defitelio would diversify our development and commercial portfolio and complement our clinical experience in hematology/oncology and our expertise in reaching targeted physicians who treat serious medical conditions,” said Bruce Cozadd, Jazz’s chairman and chief executive.

The transaction has been approved by the boards of both companies and Gentium’s board, management and certain shareholders have agreed to tender their shares, representing about 15 percent of the company’s stock. The deal is conditioned on at least 66.7 percent of the company’s shares being tendered.

The deal is expected to close in the first quarter of 2014.

Through the first nine months of the year, Jazz posted revenue of $636.6 million, a 58 percent increase over the prior-year period.

Jazz is financing the transaction with a combination of cash on hand as well as an incremental term loan and borrowings under its existing senior secured credit facility. Barclays, its financial adviser, also has committed to a $500 million incremental term loan.

Jefferies served as Gentium’s financial adviser. . Gentium’s legal advisers were Skadden Arps Slate Meagher & Flom and Gianni, Origoni, Grippo & Cappelli.

Jazz’s legal counsel were Weil, Gotshal & Manges; Baker & McKenzie; Cooley; Hogan Lovells; and Gattai, Minoli & Partners.



Tiger Asia Hedge Fund Ordered to Repay $5.8 Million Over Illegal Trading

HONG KONG â€" A court on Friday ordered Tiger Asia Management, the regional arm of the New York-based hedge fund Tiger Management, to repay nearly $6 million to more than 1,800 investors after the fund admitted to insider trading and share price manipulation.

Responding to charges brought by Hong Kong’s Securities and Futures Commission in 2009, the Justice Jonathan Russell Harris ordered Tiger Asia and two of its senior officers, Bill Hwang and Raymond Park, to pay 45.3 million Hong Kong dollars, or $5.8 million, as restitution to the investors who were on the other side of its illegal trades in the shares of Bank of China and China Construction Bank.

Tiger Asia, which last year began returning money to its investors amid pressure from insider trading investigations in Hong Kong and in the United States, admitted it had received advanced notice on separate occasions in late 2008 and early 2009 that the two Chinese banks were planning share placements. Tiger Asia acknowledged using this inside information to sell short the shares in the banks.

The restitution amount represents the difference between the actual price of the shares that were sold by Tiger Asia and the value those shares would have had if inside information on the share placements had been taken into account.
“Tiger Asia’s admissions of insider dealing and manipulation vindicate the S.F.C.’s allegations made at the outset of these proceedings,” Mark Steward, the executive director of enforcement at the securities regulator, said Friday in a statement. “Investors are unable to detect, or avoid transacting with, wrongdoers in the market and so they are highly vulnerable to this kind of misconduct.”

It is the second time this month that the S.F.C. has won a court order forcing those guilty of insider trading to pay restitution to investors. On Dec. 12, a judge ordered a former managing director at Morgan Stanley in Hong Kong, who is serving a six-year jail term for insider trading, to pay civil compensation of about $3 million to nearly 300 investors.